Tag: interest

While XRP Remains Range-Bound, PFMCrypto’s New XRP Cloud Mining Model Drives Holder Participation and Ecosystem Activity

Simplify your finances by consolidating high-interest debt into one low-interest loan. Apply today with Radcred for fast relief and better financial management.

SAN DIEGO, June 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, both dates inclusive (the “Class Period”), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc., No. 25-cv-06534 (N.D. Ill.), the Tempus AI class action lawsuit charges Tempus AI and certain of Tempus AI’s top executives with violations of the Securities Exchange Act of 1934.

DUBAI, United Arab Emirates, June 21, 2025 (GLOBE NEWSWIRE) -- Martini Market, the decentralized prediction market platform being developed on the XRP Ledger (XRPL), has confirmed that its $MRT token presale has exceeded 40% of its initial softcap target within 24 hours of launch. The strong early participation reflects rising interest in emerging use cases within the expanding XRP ecosystem.

TALLINN, Estonia, June 21, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a next-generation blockchain project, has officially entered the final stages of its highly anticipated presale. With its public launch set for July 31, 2025, the momentum around BTC-S is building rapidly as thousands of users secure early access to what many are calling one of the most accessible and performance-driven blockchain ecosystems of the year.

BTC-S: Where Scalability Meets Accessibility

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late-breaking poster presentations at the American Diabetes Association 85^th Scientific Sessions, being held from June 20-23 in Chicago, IL.